“…HCPT is currently clinically used against gastric carcinoma, hepatoma, leukemia, and tumors of head and neck in China [8,9]. Apart from the initial isolation and identification of new CPTs and their in vitro antitumor activities [4,[12][13][14], few studies were carried out on MCPT due to its higher toxicity [15]. To elucidate the potential of MCPT in the development of new anticancer drugs, we tested its antitumor activity against 2774, an ovarian cancer cell line, and MCPT showed higher cytotoxicity than HCPT.…”